| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 192.795 | 3.460.382 | 2.286.362 | 4.494.966 | 4.554.831 | 3.591.948 |
| Total Income - EUR | - | - | - | - | 192.795 | 3.460.836 | 2.295.570 | 4.526.720 | 4.594.447 | 3.604.701 |
| Total Expenses - EUR | - | - | - | - | 168.409 | 3.259.836 | 2.129.625 | 3.489.988 | 4.170.745 | 3.106.567 |
| Gross Profit/Loss - EUR | - | - | - | - | 24.386 | 201.001 | 165.945 | 1.036.733 | 423.703 | 498.133 |
| Net Profit/Loss - EUR | - | - | - | - | 18.602 | 169.655 | 145.567 | 874.051 | 358.930 | 424.976 |
| Employees | - | - | - | - | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Holde Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 2.127 | 719 |
| Current Assets | - | - | - | - | 192.705 | 947.204 | 3.781.312 | 3.103.642 | 2.195.531 | 2.183.727 |
| Inventories | - | - | - | - | 0 | 418.426 | 2.605.368 | 1.436.470 | 1.098.270 | 1.328.710 |
| Receivables | - | - | - | - | 15 | 492 | 29.202 | 91.746 | 554.556 | 348.222 |
| Cash | - | - | - | - | 192.690 | 528.285 | 1.146.743 | 1.575.426 | 542.705 | 506.795 |
| Shareholders Funds | - | - | - | - | 18.645 | 187.946 | 329.345 | 874.100 | 358.979 | 425.024 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 174.061 | 759.258 | 3.451.967 | 2.229.542 | 1.838.679 | 1.759.422 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Holde Bio S.r.l.